CD82 and prostate carcinoma: Anti-cancer 1 (KAI1), commonly referred to as CD82, has emerged as a pivotal tumor metastasis suppressor gene in recent research endeavors, initially recognized for its specific role in inhibiting metastasis in prostate cancer cells.